FDA takes new action to advance the development of reliable and beneficial genetic tests that can improve patient care
The US Food and Drug Administration has taken a significant step forward in driving the efficient development of novel diagnostic technologies that scan a person’s DNA to diagnose genetic diseases and guide medical treatments.For the first time, the agency has formally recognized a public database that contains information about genes, genetic variants and their relationship to disease. The FDA is recognizing the
To continue reading this article
Continue reading your article with a eMediNexus account.